Directed evolution of an industrial biocatalyst: 2-deoxy-D-ribose 5-phosphate aldolase
Directed evolution of an industrial biocatalyst: 2-deoxy-D-ribose 5-phosphate aldolase
复制标题
DOI:
10.1002/biot.200600020
复制
发表时间:
2006-05-01
影响因子:
4.7
通讯作者:
Mink, Daniel
中科院分区:
文献类型:
--
作者:
Jennewein, Stefan;Schurmann, Martin;Mink, Daniel
Aldolases are emerging as powerful and cost efficient tools for the industrial synthesis of chiral Received 10 March 2006 molecules. They catalyze enantioselective carbon-carbon bond formations, generating up to two Revised 4 April 2006 chiral centers under mild reaction conditions. Despite their versatility, narrow substrate ranges Accepted 5 April 2006 and enzyme inactivation under synthesis conditions represented major obstacles for large-scale applications of aldolases. In this study we applied directed evolution to optimize Escherichia coli 2deoxy-D-ribose 5-phosphate aldolase (DERA) as biocatalyst for the industrial synthesis of (3R,5S)6-chloro-2,4,6-trideoxyhexapyranoside. This versatile chiral precursor for vastatin drugs like Lipitor (atorvastatin) is synthesized by DERA in a tandem-aldol reaction from chloroacetalclehyde and two acetaldehyde equivalents. However, E coli DERA shows low affinity to chloroacetalclehyde and is rapidly inactivated at aldehyde concentrations useful for biocatalysis. Using high-throughput screenings for chloroacetaldehyde resistance and for higher productivity, several improved variants have been identified. By combination of the most beneficial mutations we obtained a tenfold improved variant compared to wild-type DERA with regard to (3R,5S)-6-chloro-2,4,6-trideoxyhexapyranoside synthesis, under industrially relevant conditions.